upset stomach on tirzepatide Diarrhea (Mounjaro) affects approximately 23–31% of patients and is typically mild to moderate, transient, and most common during dose escalation. , It rarely requires discontinuation Does Tirzepatide Cause Indigestion? Side

A review on PLGA particles as a sustained drug-delivery system and its effect on the retina

In fact, one of the most common side effects of all insulin therapy, including Toujeo, is weight gain

Jojoba oil closely resembles the skin's natural sebum, making it an ideal choice for all skin types, including oily and sensitive skin

Naunyn-Schmiedeberg's Arch Pharmacol 399 , 317327 (2026)

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Mounjaro), chronic weight management (under the brand name Zepbound), and most recently in 2024, for the treatment of adults with moderate-to-severe obstructive sleep apnea who have obesity or are overweight with at least one weight-related comorbidity

Discard the vial if exposed to heat or if expired